🎉 M&A multiples are live!
Check it out!

DexCom Valuation Multiples

Discover revenue and EBITDA valuation multiples for DexCom and similar public comparables like Myomo, InfuSystem, and SmartVest.

DexCom Overview

About DexCom

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.


Founded

1999

HQ

United States of America
Employees

10.3K+

Website

dexcom.com

Financials

LTM Revenue $4.3B

LTM EBITDA $1.2B

EV

$31.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

DexCom Financials

DexCom has a last 12-month revenue (LTM) of $4.3B and a last 12-month EBITDA of $1.2B.

In the most recent fiscal year, DexCom achieved revenue of $4.0B and an EBITDA of $946M.

DexCom expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See DexCom valuation multiples based on analyst estimates

DexCom P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $4.3B XXX $4.0B XXX XXX XXX
Gross Profit $2.7B XXX $2.4B XXX XXX XXX
Gross Margin 62% XXX 60% XXX XXX XXX
EBITDA $1.2B XXX $946M XXX XXX XXX
EBITDA Margin 29% XXX 23% XXX XXX XXX
EBIT $855M XXX $600M XXX XXX XXX
EBIT Margin 20% XXX 15% XXX XXX XXX
Net Profit $730M XXX $576M XXX XXX XXX
Net Margin 17% XXX 14% XXX XXX XXX
Net Debt XXX XXX $1.8B XXX XXX XXX

Financial data powered by Morningstar, Inc.

DexCom Stock Performance

As of June 20, 2025, DexCom's stock price is $80.

DexCom has current market cap of $31.4B, and EV of $31.3B.

See DexCom trading valuation data

DexCom Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$31.3B $31.4B XXX XXX XXX XXX $1.82

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

DexCom Valuation Multiples

As of June 20, 2025, DexCom has market cap of $31.4B and EV of $31.3B.

DexCom's trades at 7.7x EV/Revenue multiple, and 33.0x EV/EBITDA.

Equity research analysts estimate DexCom's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

DexCom has a P/E ratio of 43.0x.

See valuation multiples for DexCom and 12K+ public comps

DexCom Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $31.4B XXX $31.4B XXX XXX XXX
EV (current) $31.3B XXX $31.3B XXX XXX XXX
EV/Revenue 7.3x XXX 7.7x XXX XXX XXX
EV/EBITDA 25.4x XXX 33.0x XXX XXX XXX
EV/EBIT 36.6x XXX 52.1x XXX XXX XXX
EV/Gross Profit 11.7x XXX n/a XXX XXX XXX
P/E 43.0x XXX 54.4x XXX XXX XXX
EV/FCF 42.9x XXX 49.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get DexCom Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

DexCom Margins & Growth Rates

DexCom's last 12 month revenue growth is 15%

DexCom's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

DexCom's rule of 40 is 40% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

DexCom's rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for DexCom and other 12K+ public comps

DexCom Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 15% XXX 15% XXX XXX XXX
EBITDA Margin 29% XXX 23% XXX XXX XXX
EBITDA Growth 23% XXX 22% XXX XXX XXX
Rule of 40 40% XXX 38% XXX XXX XXX
Bessemer Rule of X XXX XXX 66% XXX XXX XXX
Revenue per Employee XXX XXX $0.4M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 14% XXX XXX XXX
Opex to Revenue XXX XXX 46% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

DexCom Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

DexCom M&A and Investment Activity

DexCom acquired  XXX companies to date.

Last acquisition by DexCom was  XXXXXXXX, XXXXX XXXXX XXXXXX . DexCom acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by DexCom

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About DexCom

When was DexCom founded? DexCom was founded in 1999.
Where is DexCom headquartered? DexCom is headquartered in United States of America.
How many employees does DexCom have? As of today, DexCom has 10.3K+ employees.
Who is the CEO of DexCom? DexCom's CEO is Mr. Kevin R. Sayer, C.P.A..
Is DexCom publicy listed? Yes, DexCom is a public company listed on NAS.
What is the stock symbol of DexCom? DexCom trades under DXCM ticker.
When did DexCom go public? DexCom went public in 2005.
Who are competitors of DexCom? Similar companies to DexCom include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of DexCom? DexCom's current market cap is $31.4B
What is the current revenue of DexCom? DexCom's last 12 months revenue is $4.3B.
What is the current revenue growth of DexCom? DexCom revenue growth (NTM/LTM) is 15%.
What is the current EV/Revenue multiple of DexCom? Current revenue multiple of DexCom is 7.3x.
Is DexCom profitable? Yes, DexCom is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of DexCom? DexCom's last 12 months EBITDA is $1.2B.
What is DexCom's EBITDA margin? DexCom's last 12 months EBITDA margin is 29%.
What is the current EV/EBITDA multiple of DexCom? Current EBITDA multiple of DexCom is 25.4x.
What is the current FCF of DexCom? DexCom's last 12 months FCF is $728M.
What is DexCom's FCF margin? DexCom's last 12 months FCF margin is 17%.
What is the current EV/FCF multiple of DexCom? Current FCF multiple of DexCom is 42.9x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.